GSK plans 1.2K+ layoffs at Belgium sites as $2.5B restructure gains momentum

GSK plans to cut over 1,200 jobs at its Belgium sites as part of a $2.5 billion global restructuring to focus capital and resources on its late-stage pipeline and R&D. This follows prior layoffs of about 650 employees at its German vaccine manufacturing site.

This Wire brief sits within Fusion42's coverage of Biotech, and 2 sources have reported it.